Associate Professor Frances Milat, MBBS (Hons) FRACP MD
- Research Group Head, Metabolic Bone Research
- Endocrinologist; Head, Metabolic Bone Services, Monash Health
- Adjunct Senior Lecturer, Dept of Medicine, School of Clinical Sciences, Monash University
- Role: Research Group HeadGroup: Metabolic Bone Research
Associate Professor Frances Milat graduated from medicine at Monash University and subsequently undertook endocrine training at Monash Health and St Vincent’s Hospital in Sydney. She pursued her research interest in metabolic bone disorders, completing a Doctor of Medicine degree at St Vincent’s Institute examining the mechanisms of PTH and the Wnt pathway action in bone.
A/Prof Milat joined the Hudson Institute of Medical Research in 2009 to continue research in osteoporosis. She is committed to improving patient care through clinical research, with interests in bone disease associated with transfusion-dependent thalassemia, chronic neurological disorders and other medical conditions. She is also involved in the supervision of research students as well as medical student and postgraduate teaching.
Amgen-GSK Osteoporosis Australia/ANZBMS Clinical Grant: The Optimisation of Bone Health in Chronic Neurological Conditions
Wong P, Fuller PJ, Gillespie MT, Kartsogiannis V, Kerr PG, Doery JC, Paul E, Bowden DK, Strauss BJ, Milat F. Thalassemia Bone Disease: A 19 Year Longitudinal Analysis. J Bone Miner Res. 2014 Apr 25. [Epub ahead of print]
Wong P, Fuller PJ, Gillespie MT, Kartsogiannis V, Milat F, Bowden DK, Strauss BJ. The Effect of Gonadal Status on Body Composition and Bone Mineral Density in Transfusion-Dependent Thalassemia. Osteoporos Int. 2014 Feb;25(2):597-604.
Milat F, Goh S, Gani LU, Suriadi C, Gillespie MT, Fuller PJ, Teede HJ, Strickland AH, Allan CA. Prolonged Hypocalcemia following Denosumab Therapy in Metastatic Hormone Refractory Prostate Cancer. Bone. 2013 Aug;55(2):305-8.
Wong P, Fuller PJ, Gillespie MT, Kartsogiannis V, Strauss BJ, Bowden D, Milat F. Thalassemia Bone Disease: The Association Between Nephrolithiasis, Bone Mineral Density and Fractures. Osteoporos Int. 2013 Jul;24(7):1965-71.
Milat, F., Wong, P., Fuller, P. J., Johnstone, L., Kerr, P. G., Doery, J. C., Strauss, B. J. and Bowden, D. K. A Case of Hypophosphatemic Osteomalacia Secondary to Deferasirox Therapy. Journal of Bone and Mineral Research. 2012 27: 219–222.